Richard Wyse Selected Research

Glucagon-Like Peptide-1 Receptor Agonists

1/2020

GLP-1 receptor agonists for Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Wyse Research Topics

Disease

8	Parkinson Disease (Parkinson's Disease) 01/2021 - 06/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 06/2013
2	Movement Disorders (Movement Disorder) 01/2020 - 01/2017
2	Weight Loss (Weight Reduction) 01/2020 - 06/2013
1	Human Influenza (Influenza) 03/2020
1	Neoplasms (Cancer) 11/2018
1	Disease Progression 10/2015
1	Eye Diseases (Eye Disease) 06/2006

Drug/Important Bio-Agent (IBA)

4	Exenatide (Byetta)FDA Link 01/2020 - 06/2013
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2017
1	IronIBA 01/2021
1	alpha-SynucleinIBA 01/2021
1	VaccinesIBA 03/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Simvastatin (Zocor)FDA LinkGeneric 10/2019
1	EnzymesIBA 11/2018
1	Pioglitazone (Actos)FDA Link 10/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2015
1	Levodopa (L Dopa)FDA LinkGeneric 06/2013

Therapy/Procedure

2	Therapeutics 10/2015 - 06/2006
1	Subcutaneous Injections 01/2017
1	Drug Therapy (Chemotherapy) 06/2006